Stairmed develops implantable brain-computer interfaces for interaction between the brain and external devices.
Established in 2021 and based in Shanghai, China, Stairmed develops implantable brain-computer interface technology. Its work aims to support two-way communication between the brain and external devices for function restoration, disease treatment, and enhancement. The company applies ultra-flexible electrodes to reduce the size of implants. In March 2026, it raised CNY 500 million in strategic investment led by Alibaba Ventures, with SDIC Unity Capital, Tencent Investment, Source Code Capital, FountainBridge Capital, OrbiMed Advisors, Oriza Holdings, Qiming Venture Partners, Lilly Asia Ventures, and Shanghai State-owned Capital Investment Leading Fund participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in